A recombinant CD99-targeted antibody–drug conjugate for Ewing sarcoma therapy
- DOI
- 10.1016/j.bcp.2026.118591
- Published
- 2026-12
- Container
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118591,
title = {A recombinant CD99-targeted antibody–drug conjugate for Ewing sarcoma therapy},
author = {Yogalakshmi Sabapathy and Balaji Ramachandran and Priya Ramanathan and Shirley Sundersingh and Nazeer Yasin and Narayanan Madaboosi and Guhan Jayaraman and Pazhanivel Natesan and Gopal Gopisetty and Rajkumar Thangarajan},
year = {2026},
journal = {Biochemical Pharmacology},
doi = {10.1016/j.bcp.2026.118591},
url = {https://doi.org/10.1016/j.bcp.2026.118591}
}RIS
TY - JOUR TI - A recombinant CD99-targeted antibody–drug conjugate for Ewing sarcoma therapy AU - Yogalakshmi Sabapathy AU - Balaji Ramachandran AU - Priya Ramanathan AU - Shirley Sundersingh AU - Nazeer Yasin AU - Narayanan Madaboosi AU - Guhan Jayaraman AU - Pazhanivel Natesan AU - Gopal Gopisetty AU - Rajkumar Thangarajan PY - 2026 JO - Biochemical Pharmacology DO - 10.1016/j.bcp.2026.118591 UR - https://doi.org/10.1016/j.bcp.2026.118591 ER -
APA
Sabapathy, Y., Ramachandran, B., Ramanathan, P., Sundersingh, S., Yasin, N., Madaboosi, N., Jayaraman, G., Natesan, P., Gopisetty, G., & Thangarajan, R. (2026). A recombinant CD99-targeted antibody–drug conjugate for Ewing sarcoma therapy. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118591
Source records
- crossref · retrieved 2026-11-10T10:57:19.043Z